Intrinsic Value of S&P & Nasdaq Contact Us
English English 中文(简) 中文(简) 中文(繁) 中文(繁) हिन्दी हिन्दी Español Español 日本語 日本語 한국어 한국어 Deutsch Deutsch Français Français
← Back to all stocks

FOXO Technologies Inc. FOXO OTC

Other OTC • Healthcare • Medical - Healthcare Information Services • US • USD

SharesGrow Score
24/100
0/5 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow

FOXO Technologies Inc. (FOXO) is a Medical - Healthcare Information Services company in the Healthcare sector, currently trading at $0.00. It has a SharesGrow Score of 23/100, indicating a weak investment profile with 0 out of 7 criteria passed.

Financials: revenue is $4M, +981%/yr average growth. Net income is $12M (loss), growing at -7.4%/yr. Net profit margin is -306.2% (negative). Gross margin is 38.7% (-61.3 pp trend).

Balance sheet: total debt is $14M against $5.3B equity (Debt-to-Equity (D/E) ratio 0, conservative). Current ratio is 0.09 (tight liquidity). Debt-to-assets is 0%. Total assets: $41.7B.

SharesGrow 7-Criteria breakdown: Value ?/100 (Fail), Growth 58/100 (Partial), Past 0/100 (Fail), Health 33/100 (Fail), Moat 21/100 (Fail), Future ?/100 (Fail), Income 10/100 (Fail).

FOXO SharesGrow Score Overview

31/100
SharesGrow Score
Below average — proceed with caution
View full scorecard →
VALUE 0/100
Valuation — P/E, PEG, Forward PEG
GROWTH 58/100
Financials — average growth
PAST 0/100
strong — trend
HEALTH 33/100
Balance sheet — Debt-to-Equity (D/E) ratio, Current ratio is
MOAT 21/100
Gross margin is + market cap
FUTURE 0/100
Analyst outlook — as buy
INCOME 10/100
Net profit margin is
Scores derived from financial statements, analyst ratings, and balance sheet data.

Score Breakdown — FOXO

—
VALUE N/A
N/A
No analyst coverage available for this stock.
~
GROWTH Partial
58/100
FOXO: +981%/yr revenue is, -7.4%/yr Net income is average growth. mixed. Score: >20%/yr = 100, >10% = 80, >5% = 65, >0% = 45, < 0 = 15.
View details →
—
PAST N/A
N/A
No analyst coverage available for this stock.
✗
HEALTH Fail
33/100
Balance sheet FOXO: Debt-to-Equity (D/E) ratio 0 (conservative), Current ratio is 0.09 (tight liquidity). Debt-to-Equity < 0.5, Current Ratio > 1.5, Interest Coverage > 8x = ideal. ≥ 70 = Pass.
View details →
✗
MOAT Fail
21/100
FOXO: Gross margin is 38.7% (-61.3 pp trend), N/A market cap. Moat (0-100): margin (35%) + trend (15%) + market cap (30%) + revenue is (20%). Score 21/100. ≥ 70 = Pass.
View details →
—
FUTURE N/A
N/A
No analyst coverage available for this stock.
✗
INCOME Fail
10/100
FOXO: Net profit margin is -306.2%. negative. Score: ≥30% = 100, ≥20% = 85, ≥15% = 70, ≥10% = 55, ≥5% = 45, ≥0% = 30, < 0 = 10.
View details →

Stock Chart & Stats

Market Data
52-Week Range0.00005-4.7362
Volume1.59M
Avg Volume (30D)20.2M
Market Cap$3K
Beta (1Y)2.59
Share Statistics
EPS (TTM)-0.85
Shares Outstanding$14.61M
IPO Date2022-09-16
Employees102
CEOSeamus Lagan
Financial Highlights & Ratios
Revenue (TTM)$4.05M
Gross Profit$1.57M
EBITDA$-7.28M
Net Income$-12.41M
Operating Income$-7.76M
Total Cash$68.27K
Total Debt$14.25M
Net Debt$14.19M
Total Assets$41.71B
Price / Earnings (P/E)-0
Price / Sales (P/S)0
Analyst Forecast
Company Info
CountryUS
ExchangeOther OTC
CurrencyUSD
ISINUS3514715032

Price Chart

Track all markets on TradingView
FOXO
FOXO Technologies Inc. ↗  ·  Other OTC
Healthcare • Medical - Healthcare Information Services
0.00 52WK RANGE 4.74

People Also View

NUTX
NUTX
Nutex Health, Inc.
$107.84
+1.48%
 AUGX
AUGX
Augmedix, Inc.
$2.35
-0.21%
 BEAT
BEAT
HeartBeam, Inc.
$1.20
+0.42%
 SNCE
SNCE
Science 37 Holdings, Inc.
$5.75
+0.35%
 EUDA
EUDA
EUDA Health Holdings Limited
$6.88
+1.03%
 ETAO
ETAO
ETAO International Co., Ltd.
$1.91
-31.79%
 MGRX
MGRX
Mangoceuticals, Inc.
$0.39
-1.35%
 HCTI
HCTI
Healthcare Triangle, Inc.
$2.60
+3.17%
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
📧 [email protected]
📞 +65 8912 8000
Send us a message